Tag: Bureau of Competition

Displaying 21 - 40 of 486 results.

There is still time to submit public comments on the FTC’s proposal to study the effectiveness of its remedial orders in merger cases. Fifteen years have passed since the Bureau’s previous Divestiture Study, which resulted in a number of important findings that caused the Commission...
Pharmaceutical companies Impax Laboratories Inc. and CorePharma, LLC have agreed to divest all of CorePharma’s rights and assets to generic pilocarpine tablets and generic ursodiol tablets, in order to settle  Federal Trade Commission charges that Impax’s proposed $700 million acquisition of...
Although FTC staff often rely on voluntary requests for information in the early stages of an investigation, the use of official subpoena and civil investigative demands authorized by the Commission is essential to uncover potential law violations, and when necessary, to pursue a law...
Following a public comment period, the Federal Trade Commission has approved an application from Community Health Systems to sell Riverview Regional Medical Center and its associated assets near Gadsden, Alabama.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Eli Lilly and Company’s acquisition of Novartis Animal Health would likely be anticompetitive.
Following a public comment period, the Federal Trade Commission has approved final orders settling charges in two separate cases alleging that the bylaws of the trade associations restrained competition.  
Yesterday, the Supreme Court affirmed the Fourth Circuit’s decision to uphold the FTC’s order against the North Carolina State Board of Dental Examiners In a tour-de-force opinion laying out the proper scope of the state action doctrine first articulated in Parker v.
Following a public comment period, the Federal Trade Commission has approved an application from the owners of Surgery Center Holdings, known as Surgery Partners to divest Symbion Holdings Corporation’s ownership interest in the Blue Springs Surgery Center in Orange City, Florida, to Dr. Mark W....
“Today, the Supreme Court affirmed the FTC's position in recognizing that a state may not give private market participants unsupervised authority to suppress competition even if they act through a formally designated ‘state agency’."
Global pharmaceutical company Novartis AG has agreed to divest all assets related to its BRAF and MEK inhibitor drugs, currently in development, to Boulder, Colorado-based Array BioPharma to settle charges that Novartis’s $16 billion acquisition of GlaxoSmithKline’s portfolio of cancer-treatment...
As anyone of a certain age can attest, the 1970’s were all about change. Hairstyles and hemlines were obvious signs, but in the world of antitrust, change came in the form of applying competition standards to the “learned professions,” and new thinking about the role of competition...
Agency Charges Merger Would Create a National Broadline Foodservice Distributor With 75 Percent Market Share, and Harm Customers in Numerous Local Markets
Reminder: your appointment is coming up soon! Staff of the Federal Trade Commission and the U.S. Department of Justice Antitrust Division just posted the agenda for next week’s two-day health care workshop. One look, and you won’t need a second opinion – you definitely will want to...
The Federal Trade Commission and the U.S. Department of Justice’s Antitrust Division have issued an agenda and posted speaker bios for their joint workshop in the series Examining Health Care Competition. The workshop will take place on February 24-25, 2015, in the Constitution Center Auditorium...
Following a public comment period, the Federal Trade Commission has approved an application for prior approval from Merck & Co., Inc. to sell its Barcelonata facility to Merial Barceloneta LLC, a subsidiary of Merial Inc. Merck currently contract-manufactures the canine heartworm medications...
The Ninth Circuit today affirmed the district court’s ruling that the merger of St. Luke’s Health Systems, Ltd. and Saltzer Medical Group violated Section 7 of the Clayton Act. Nearly two years ago, the Commission and the State of Idaho filed a complaint in federal court alleging...
The decision affirms the decision by the U.S. District Court in the District of Idaho, which held that the acquisition violated Section 7 of the Clayton Act and the Idaho Competition Act, and ordered St. Luke’s to fully divest itself of Saltzer’s physicians and assets.
Take a deep breath and hold it. Release. Now open your mouth and say, “aaahhh.” Just as it is prudent to have your health examined regularly by professionals, we believe it is wise to periodically examine the competitive dynamics in the ever-evolving health care marketplace, a...
The Federal Trade Commission has submitted to Congress its Fiscal Year 2016 budget request, which includes the FY 2016 Budget Overview Statement, Performance Plan for FY 2015 and FY 2016, and Performance Report for FY 2014, as required under the Government Performance and Results and Modernization...
Pharmaceutical companies Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. have agreed to divest Ranbaxy’s interests in generic minocycline tablets  in order to settle Federal Trade Commission charges that Sun’s $4 billion proposed acquisition of Ranbaxy would likely be...

Pages